Drug Insights

Effortless Searching: How to Find Metronidazole on Synapse

1 February 2024
2 min read

Metronidazole, a small molecule drug approved in 1960 by Pfizer Inc., inhibits DNA synthesis and is highly effective against anaerobic bacteria and protozoa. Its versatility is demonstrated by its indication for a wide range of conditions, including skin ulcers, enteritis, Helicobacter pylori infection, rosacea, trichomonas vaginitis, and amebiasis. By disrupting DNA synthesis, metronidazole inhibits growth and multiplication of these microorganisms. It also shows potential as a substitute therapy for some antibiotic-resistant bacterial infections. However, like all drugs, metronidazole has potential adverse effects such as nausea, regurgitation, and metallic taste in the mouth. Patients should carefully follow prescribed dosages and treatment durations to avoid antibiotic resistance and the risk of side effects. Click on the image below to begin the exploration journey of Metronidazole through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Onward Therapeutics Starts Recruiting for OT-A201 Dual-Targeted Antibody Clinical Study
Latest Hotspot
3 min read
Onward Therapeutics Starts Recruiting for OT-A201 Dual-Targeted Antibody Clinical Study
1 February 2024
Onward Therapeutics has begun recruiting for an initial phase clinical study of their innovative dual-targeted antibody, OT-A201, which engages with two distinct immune control points.
Read →
Making the Most Out of Synapse: Searching for Pantoprazole
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Pantoprazole
1 February 2024
Pantoprazole is a small molecule medicine classed as a proton pump inhibitor, which means it reduces the amount of acid generated in the stomach.
Read →
Synapse Simplified: How to Find Ivermectin Information
Drug Insights
2 min read
Synapse Simplified: How to Find Ivermectin Information
1 February 2024
Ivermectin, a small molecule drug, operates as a modulator of the glutamate-gated chloride channel, an action that forms the basis of its pharmacological activity.
Read →
PharmAbcine Begins Early-Stage PMC-309/KEYTRUDA Trial for Severe Solid Cancers
Latest Hotspot
3 min read
PharmAbcine Begins Early-Stage PMC-309/KEYTRUDA Trial for Severe Solid Cancers
1 February 2024
PharmAbcine Initiates Dosing in Early-Stage Study for PMC-309 with KEYTRUDA (pembrolizumab) in Subjects Facing Severe Solid Cancers.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.